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Abstract 
Partial mole occurs when an egg is fertilized by two spermatozoids or by one spermatozoid which reduplicates 
itself yielding most commonly triploid genotype of 69,XXY. We present a case of a partial hydatidiform mole 
associated with multinodular goiter. The patient is a 27-year-old primigravida who presented for termination of 
non-viable pregnancy at 11 weeks gestation. Her ultrasound examination showed lack of growth and presence of 
degenerative changes. Thyroid gland ultrasound scan revealed multinodular goiter. Flow cytometry analysis 
showed triploid pick index of 1.46 which confirmed the triploid karyotype (69, ХХУ) detected by genetic 
studies. Partial hydatidiform mole could be a risk factor for the occurrence of nodular goiter and even 
hyperthyroidism as the underlying hormonal imbalance triggers pathogenetic mechanisms of the thyroid 
dysfunction. 
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1. Introduction  
Hydatidiform mole is a form of gestational trophoblastic disease which affects the ovum and the developing 
trophoblast. The importance of correct diagnosis stems from its association with an increased risk of persistent 
trophoblastic disease (invasive mole) or choriocarcinoma. The incidence varies considerably in different regions 
of the world. Two types of moles—complete and partial—can be identified by cytogenetic and histologic 
studies. Majority of complete moles result from fertilization of an ovum that has lost its chromosomes, and the 
genetic material is completely paternally derived. Most complete moles have a 46,XX diploid complement 
derived from duplication of the genetic material of one sperm (a phenomenon called androgenesis). The embryo 
usually dies very early in development. Patients have 2.5% risk of subsequent choriocarcinoma. Partial mole 
occurs when an ovum is fertilized by two sperms or by one sperm which reduplicates itself resulting most 
commonly in triploid genotype of 69,XXY. Fetal/embryonic tissue and/or embryonic red blood cells are usually 
identified on histologic examination and the risk of choriocarcinoma is considerably less compared to complete 
mole. 
2. Case report 
 We present a case of partial hydatidiform mole with triploidy 69 XXY associated with multinodular goiter. The 
patient is a healthy-appearing 27-year-old primigravida who presented for termination of non-viable pregnancy 
at 11 weeks gestation.  
On early prenatal ultrasound examination an yolk sac and gestational sac were visualized and fetal heart rate 
was detected. Subsequent scan revealed a lack of growth, no fetal heart activity and presence of degenerative 
changes.  
 
Figure 1: Ultrasound of thyroid gland. Multinodular goiter. 
At the same time a prophylactic ultrasound scan of the thyroid gland revealed multinodular goiter with no 
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palpable lesions on physical examination. (Figure 1) 
Biochemical analysis showed a TSH of 1,23 mIU/L (0.4 - 4.0) and a β- hCG of 1832 mIU/mL corresponding to 
5 weeks gestational age.  
Patient reported using topical Retinoic acid solutio - Locacid lot. 0,1%, 1mg/1ml for several months prior to and 
during pregnancy.   
Family history is significant for maternal great-grandmother with recurrent miscarriages and a history of 
congenital anomalies of paternal siblings, including a Down syndrome. 
Following appropriate consent, pathology examination of miscarriage material was performed with subsequent 
genetic and immunohistochemical analysis on placental tissue.  
Macroscopic pathology examination of the products of conception revealed multiple 1 to 2 mm in diameter 
translucent vesicles. (Figure 2). 
 
Figure 2: Uterine contents after curettage showing multiple 1-2 mm translucent vesicles. 
Microscopic examination revealed the presence of two populations of chorionic villi, one of which showed 
enlarged hydropic villi with irregualr contour and trophoblastic pseudoinclusions. Embryonic red blood cells 
were noted within villous capillaries which is an evidence of embryonic development. (Figure 3) 
Immunohistochemistry analysis with antibodies to p57,kip2, a cyclin-dependent kinase inhibitor 1C, showed 
positive expression of villous cytotrophoblast, villous stromal cells, and extravillous trophoblast.  
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Flow cytometry analysis performed on paraffin embedded villous tissue showed triploid pick of 1.46 for 91.31% 
of the cells, which confirmed the triploid karyotype (69, ХХУ) detected by genetic studies. 
 
Figure 3:  Photomicrograph of histology section showing a hydropic chorionic villus with irregular contours 
and trophoblast pseudoinclusions. H&E 10X magnification. 
3. Discussion 
3.1. Differential diagnosis 
Complete hydatidiform mole - in 90% of cases, the zygote is the result of fusion of the ovum with a single 
sperm cell and only in 10% - with two sperms. 
Unlike partial mole, genetic analysis shows diploid set of chromosomes – 46XY or 46XX. Histologically, the 
chorionic villi are large, distended with cistern formation and exuberant circumferential proliferation of the 
villous trophoblast. Immunohistochemical analysis with kip 2 p 57 antibody shows lack of expression of the 
villous cytotrophoblast and villous stromal cells. There is a 2-3% risk of complete moles developing into 
choriocarcinoma, and approximately 20% developing into invasive mole. Risk of choriocarcinoma arising from 
partial mole is negligible. Therefore, it is imperative to rule-out complete hydatidiform mole. 
Choriocarcinoma. Gestational choriocarcinoma is an epithelial malignant neoplasm of trophoblastic cells 
derived from any form of previously normal or abnormal pregnancy. Choriocarcinoma is a rapidly invasive, 
widely metastasizing malignant neoplasm, but once it is identified, it responds well to chemotherapy. 
Placental site trophoblastic tumor (PSTT) is a tumor arising from the intermediate trophoblast. PSTTs comprise 
less than 2% of gestational trophoblastic neoplasms and present as neoplastic polygonal cells infiltrating the 
endomyometrium of the uterus. Overall, about 10% result in disseminated metastases and death. Distinction of 
PSTTs from normal exaggerated placental implantation site trophoblast may be difficult and can be achieved by 
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using biomarkers (Mel-Cam and Ki-67) that detect increased proliferation in the trophoblastic cells. 
The histopathologic findings in this case are highly suspicious for a partial hydatidiform mole. 
Immunohistochemical analysis revealed normal expression of p57, Kip2 of the villous cytotrohoblast, villous 
stromal cells and extravillous trophoblast. This pattern of staining practically excludes complete mole, which is 
an important differential diagnostic consideration due to its association with increased risk for choriocarcinoma. 
Complete moles show negative staining for p57, Kip2 of the villous cytotrohoblast and villous stromal cells. 
Flow cytometry results revealed triploid genetic complement of the villous tissue analyzed, which is in 
agreement with the genetic results and supports the diagnosis of a partial hydatidiform mole since most partial 
moles are triploid. Complete moles, on the other hand, are diploid with all the genetic material derived 
paternally. The final diagnosis is partial hydatidiform mole. 
3.2. Endocrine aspects  
There are reasons to believe that hyperthyroidism is due to cross-reactivity of the TSH receptor and molecular 
mimicry between human chorionic gonadotropin (HCG) and thyroid stimulating hormone (TSH) [1]. Human 
chorionic gonadotropin is a glycoprotein composed of α and β subunits, in which the α subunit is almost 
identical to that of TSH [2]. Thyroid stimulation is proportional to the concentration of HCG and depends on the 
deglycosylation, and/or desialylation in the metabolism of HCG and can lead to increased thyrotropic effects 
[3]. Cross-reactivity between the two hormones has also been confirmed by in vitro experiments [4].  
The patient in our case had a multinodular goiter without increased TSH associated with a partial hydatidiform 
mole. The combination of these findings is highly suggestive of cross-reactivity between the two hormones. 
3.3. Genetic aspects 
 We identified the genotype of our case as triploid (69 XXY), which proves the paternal origin of the extra 
haplotype, a phenomenon known as diandric triploidy. Duplication of the haploid chromosomal set in the sperm 
may be the result of an error in meiosis [5].  
Triploidy is a type of aneuploidy, which on the other hand is the most common cause of miscarriage in the first 
trimester of pregnancy [6]. It should be noted that partial hydatidiform mole is not synonymous with triploidy 
syndrome. Triploidy refers to a complete extra set of haploid chromosomes derived from the mother (digynic) or 
the father (diandric). When the triploid is diandric, the placenta is enlarged and the histology is consistent with a 
partial hydatidiform mole. The fetus is mildly growth restricted. By comparison, a digynic triploid is associated 
with severe fetal growth restriction, relative macrocephaly, and a small, noncystic placenta.  
Advanced maternal age appears to be a risk factor for non-disjunction of the maternal meiotic division [7]. 
Extremes of maternal reproductive age, younger than 16 years and older than 50 years, is associated with 
significantly increased risk for molar gestation. Potential risk factors for the development of partial hydatidiform 
mole could be related to nutritional deficiencies and toxic effects of diets low in protein, folic acid, and carotene 
[8]. Recent research confirms the pulse effects of retinoic acid on meiosis and differentiation of sperms. The 
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clinical history of the presented case reveals evidence of retinoic acid use; however the significance of that 
exposure is difficult to interpret. 
4. Conclusion 
 Partial hydatidiform mole could be a risk factor for the occurrence of nodular goiter and even hyperthyroidism 
as the underlying hormonal imbalance triggers pathogenetic mechanisms of the thyroid dysfunction. Therefore, 
the importance of follow-up and close monitoring of TSH and thyroid hormones for planning and managing 
affected pregnancies cannot be overstated. 
On the other hand, the current advanced methods for diagnosis of triploidy and hydatidiform mole, including 
histopathologic, genetic and immunohistochemical analysis, should become routine practice for better patient 
care. 
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